Testing a slow-release DHEA for asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests a slow-release form of DHEA, a natural hormone, to see if it safely improves asthma control in people who already use daily steroid inhalers. It's looking for adults aged 18 to 50 with diagnosed asthma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old
- You have asthma diagnosed by a doctor
- You have used a daily inhaled steroid (like Flovent or Qvar) for at least the past 2 months
- You do not smoke, vape, or have smoked for more than 5 pack-years (about a pack a day for 5 years)
- You are not pregnant, breastfeeding, or trying to become pregnant (if female)
- You do not have other serious lung diseases or long-term health problems that would interfere
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether stepping up to either a higher dose of inhaled steroid/long-acting bronchodilator or a special fine-particle triple therapy (which includes an extra medication) can improve small-airway health in people whose asthma is still not well controlled on a medium-dose combination.
This study tests an investigational drug to see if it can improve asthma control in people whose asthma is not well managed with current treatments. It may help reduce symptoms and improve lung function.
This study is testing an investigational medication for people with uncontrolled asthma. Participants must have moderate-to-severe asthma, be on appropriate maintenance therapy, and meet specific safety criteria.
This study tests whether taking ginger can help people whose asthma is not well controlled with their current inhalers. If you join, you will take ginger supplements and monitor your asthma symptoms and breathing tests.
This trial tests whether a new inhaler (CHF5993) works as well as the current standard for adults with mild to moderate asthma. It compares how well the medicine controls asthma and opens airways.
This study tests a new three-part asthma inhaler (CHF 5993) in people whose asthma isn't well-controlled even though they're already using two standard asthma medicines together. The goal is to see if adding this new medicine helps control asthma better.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.